Michelle M. Cummins

Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study

Niall C. Tebbutt, Kate Wilson, Val Gebski et al. · Journal of Clinical Oncology · 2010 · 412 citations · Full text

Impact of <i>KRAS</i> and <i>BRAF</i> Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer

Timothy Price, Jennifer E. Hardingham, Chee Khoon Lee et al. · Journal of Clinical Oncology · 2011 · 209 citations · Full text

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial

Yoland Antill, Peey‐Sei Kok, Kristy Robledo et al. · Journal for ImmunoTherapy of Cancer · 2021 · 120 citations · Full text

Vocal fold paresis

James A. Koufman, Gregory N. Postma, Michelle M. Cummins et al. · Otolaryngology · 2000 · 110 citations

Music, Phoniatrics, Vocal Fatigue +13

Immunohistochemical analysis of the proliterative capacity of duct and acinar cells during ligation‐induced atrophy and subsequent regeneration of rat parotid gland

Aileen P. Burford‐Mason, Michelle M. Cummins, Dale H. Brown et al. · Journal of Oral Pathology and Medicine · 1993 · 62 citations